From time to time, it’s necessary for the RQA Board to review and reconsider the rules which define what the Association does. Most of those rules are stated in the Articles of Association, which must be accepted by RQA members before filing at Companies House.
In the latest revision to the Articles, the Board took the opportunity to expand the number of Board Members from five to seven. The Board felt that by enlarging the Board size slightly, the scope of knowledge and experience would increase.
The Board also altered the term of office for a Board member, which will now begin on 1st January. The change allows sufficient time after the Annual General Meeting (AGM) to complete the Board induction before the Strategy Meeting at the end of January.
The revised Articles were accepted, by members, at the AGM.
Since new Board members cannot be elected until the next RQA AGM on 6th November 2019, the Board decided to use its powers of co-option to appoint three new Board members (including one to fill the vacant position):
Their term of office commenced on 1st January 2019 and will run until the end of the year.
Kath Williams, the Chair of the Board, said: “I’m sure Sameera, Matt and Tim will use their knowledge and experience to add a new perspective to the RQA Board”.
The RQA Board is made up of seven Board Members.
The Chairman of the Board is Kath Williams
The Treasurer is Roger Cope
Board Member with responsibility for Global Engagement is Tracy Gilbert
Past Chair is Vanessa Grant
Animal and Veterinary Product Committee - Sven Buckingham
DIGIT Committee (formerly the Computing Committee) - Trev Simmons
Good Clinical Practice Committee - Glene Sandom
Good Laboratory Practice Committee - Mark Goodwin
Good Manufacturing Practice Committee - Julie Giblin
Good Pharmacovigilance Practice Committee - Louise Handy
Medical Devices Committee - Colette McIntyre